Study of Ocular Transport of Drugs Released from an Intravitreal Implant Using Magnetic Resonance Imaging
暂无分享,去创建一个
Nam Sun Wang | Robert J. Lutz | Hyuncheol Kim | Michael R. Robinson | Martin J. Lizak | Karl G. Csaky | N. Wang | K. Csaky | M. Lizak | R. Lutz | Hyuncheol Kim | M. Robinson | P. Yuan | Ginger Tansey | Peng Yuan | G. Tansey
[1] Jing Xu,et al. Permeability and Diffusion in Vitreous Humor: Implications for Drug Delivery , 2004, Pharmaceutical Research.
[2] T. Cox,et al. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. , 2002, Experimental eye research.
[3] Jing Xu,et al. Computer Simulation of Convective and Diffusive Transport of Controlled-Release Drugs in the Vitreous Humor , 2004, Pharmaceutical Research.
[4] P. A. Pearson,et al. An intravitreal device providing sustained release of cyclosporine and dexamethasone. , 1994, Current eye research.
[5] L. Ambrosio,et al. Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. , 2001, Biomaterials.
[6] K. Tojo,et al. In Vivo/In Vitro Correlation of Intravitreal Drug Delivery from Biodegradable Polymer Implants , 2002 .
[7] R Weissleder,et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.
[8] Sridhar Duvvuri,et al. Drug delivery to the retina: challenges and opportunities , 2003, Expert opinion on biological therapy.
[9] A. Hughes,et al. A schematic eye for the rabbit. , 1972, Vision research.
[10] K. Brindle,et al. Measurement of bioreactor perfusion using dynamic contrast agent-enhanced magnetic resonance imaging. , 2001, Biotechnology and bioengineering.
[11] I. Fatt. Flow and diffusion in the vitreous body of the eye. , 1975, Bulletin of mathematical biology.
[12] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.
[13] S. Whitcup,et al. New developments in sustained release drug delivery for the treatment of intraocular disease , 1999, The British journal of ophthalmology.
[14] S. Fliesler,et al. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. , 1987, Archives of ophthalmology.
[15] Y. Ogura,et al. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. , 2003, Investigative ophthalmology & visual science.
[16] R. Balaban,et al. MRI of the human eye using magnetization transfer contrast enhancement. , 2000, Investigative ophthalmology & visual science.
[17] P. Sado,et al. Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.
[18] J. Jonas,et al. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. , 2003, Archives of ophthalmology.
[19] B Dhillon,et al. Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS , 1998, International journal of STD & AIDS.
[20] C. Wilson,et al. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection. , 1991, Investigative ophthalmology & visual science.
[21] Daniel F. Martin,et al. Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. , 2003, American journal of ophthalmology.
[22] P. Joseph,et al. Ocular MR imaging and spectroscopy: an ex vivo study. , 1986, Radiology.
[23] T. Freddo,et al. Contrast-enhanced magnetic resonance imaging confirmation of an anterior protein pathway in normal rabbit eyes. , 1996, Investigative ophthalmology & visual science.
[24] P. Tofts,et al. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. , 1992, Investigative ophthalmology & visual science.
[25] O. Findl,et al. Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents , 2001, The British journal of ophthalmology.
[26] J. Jonas,et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. , 2003, Archives of ophthalmology.
[27] P. Missel. Hydraulic Flow and Vascular Clearance Influences on Intravitreal Drug Delivery , 2002, Pharmaceutical Research.
[28] J. Rohen,et al. Short-term hemodynamic changes in episcleral arteriovenous anastomoses correlate with venous pressure and IOP changes in the albino rabbit. , 1996, Current eye research.
[29] T. Freddo,et al. Evaluation of therapeutic effectiveness using MR imaging in a rabbit model of anterior uveitis. , 2002, Experimental eye research.
[30] A. Mitra,et al. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. , 2001, Experimental eye research.
[31] K. Tojo,et al. Pharmacokinetic model of intravitreal drug injection. , 1994, Mathematical biosciences.
[32] K. Tojo,et al. Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery. , 2001, Advanced drug delivery reviews.
[33] J. Lim,et al. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. , 1999, American journal of ophthalmology.
[34] K. Tojo,et al. A pharmacokinetic model of intravitreal delivery of ganciclovir. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[35] B. Saville,et al. Finite element modeling of drug distribution in the vitreous humor of the rabbit eye , 1997, Annals of Biomedical Engineering.
[36] X Huang,et al. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[37] B. Woods,et al. Visualization of water movement in the living rabbit eye , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[38] D. Maurice,et al. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. , 1991, Experimental eye research.
[39] D. Maurice. Flow of water between aqueous and vitreous compartments in the rabbit eye. , 1987, The American journal of physiology.
[40] N. Yamamoto,et al. Detection of CMV DNA in the Aqueous Humor of AIDS Patients with CMV Retinitis by AMPLICOR CMV Test , 2003, Ophthalmologica.
[41] Edward L Cussler,et al. Diffusion: Mass Transfer in Fluid Systems , 1984 .
[42] C. R. Ethier,et al. Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel magnetic resonance imaging method. , 1999, Biotechnology and bioengineering.
[43] R. Brubaker,et al. Measurement of aqueous flow in rabbits with corneal and vitreous depots of fluorescent dye. , 1986, Investigative ophthalmology & visual science.
[44] P. Missel. Finite and Infinitesimal Representations of the Vasculature: Ocular Drug Clearance by Vascular and Hydraulic Effects , 2004, Annals of Biomedical Engineering.
[45] E. de Juan,et al. In vivo imaging of breakdown of the inner and outer blood-retinal barriers. , 1992, Investigative ophthalmology & visual science.
[46] K. Tojo,et al. In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation. , 1994, Biological & pharmaceutical bulletin.